Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.7450 (-0.81%) ($28.4600 - $29.1250) on Tue. Sep. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.28% (three month average) | RSI | 51 | Latest Price | $28.7450(-0.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 0.4% a day on average for past five trading days. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.14% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) EDOC(-3%) TLT(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.14% (StdDev 2.28%) | Hourly BBV | 0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $28.41(1.18%) | 10 Day Moving Average | $28.33(1.46%) | 20 Day Moving Average | $28.47(0.97%) | To recent high | -2.9% | To recent low | 26% | Market Cap | $3.929b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |